Publications by authors named "Matteo Porta"

Claim this Profile
R
Rarer than rare: managing an epiphrenic diverticulum in achalasia.
Giovanni Aldinio, Caterina Pelligra, Laura Cini, Marina Coletta, Beatrice Marinoni, Matteo Porta

Endoscopy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 Patients.
Saubia Fathima, Ali Alsugair, Muhammad Yousuf, Priyansh Faldu, Clifford Csizmar, Matteo G Della Porta

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Data Generated by Artificial Intelligence to Optimize Surgical Trial Design.
Caterina Foppa, Saverio D'Amico, Mattia Delleani, Annalisa Maroli, Victor Savevski, Matteo Giovanni Della Porta

Ann Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia.
Jowan Al-Nusair, Luca Lanino, Arda Durmaz, Matteo Giovanni Della Porta, Amer M Zeidan

Blood Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee.
Jaime Sanz, Gesine Bug, Fabio Ciceri, Charles Craddock, Richard Dillon, Matteo Giovanni Della Porta

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.
Elena Zazzetti, Saverio D'Amico, Flavia Jacobs, Rita De Sanctis, Lorenzo Chiudinelli, Matteo G Della Porta

JCO Clin Cancer Inform· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms.
Savanah D Gisriel, Fnu Aakash, John M Bennett, Robert P Hasserjian, Sanam Loghavi, Matteo G Della Porta

Arch Pathol Lab Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.
Marco G Raddi, Sophie Park, Michaela Fontenay, Olivier Kosmider, Maria Diez Campelo, Matteo G Della Porta

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and outcome variability in hernia-related small bowel obstruction: insights from the SnapSBO study.
Matteo Maria Cimino, Gary Alan Bass, Hayato Kurihara, Gabriele Bellio, Matteo Porta

BJS Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers.
Prajwal C Boddu, Rahul Roy, Stephen Hutter, Francis Baumgartner, Wenxue Li, Matteo Giovanni Della Porta

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.
Gregorio Maria Bergonzi, Jacques-Emmanuel Galimard, Federico Mario Aletti, Piera Angelillo, Sara Mastaglio, Matteo G Della Porta

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.
Margherita Maffioli, Barbara Mora, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Matteo Giovanni Della Porta

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome.
James M Foran, Guillermo F Sanz, Justin M Watts, Andrew M Brunner, Gaelle Fossard, Matteo Giovanni Della Porta

Leuk Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised placebo controlled clinical investigation.
Mariangela Rondanelli, Simone Perna, Matteo Della Porta, Federico Lombardoni, Zaira Patelli

BMC Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells from myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo.
Alessandra Ferrelli, Syed Mian, Marion Piganeau, Hector Huerga Encabo, Despoina Papazoglou, Matteo Giovanni Della Porta

Hemasphere· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.
Guillermo Garcia-Manero, Valeria Santini, Amer M Zeidan, Rami S Komrokji, Veronika Pozharskaya, Matteo Giovanni Della Porta

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes.
Matteo Zampini, Elena Riva, Luca Lanino, Elisabetta Sauta, Rita Antunes Dos Reis, Matteo Giovanni Della Porta

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT.
Carmelo Gurnari, Marie Robin, Lionel Adès, Mahmoud Aljurf, Antonio Almeida, Matteo Giovanni Della Porta

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron trapping in macrophages reshapes the homeostasis of the haematopoietic system.
Laura Crisafulli, Margherita Correnti, Elena Gammella, Elisa De Camilli, Matteo Brindisi, Matteo G Della Porta

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Marco Cerrano, Matteo Giovanni Della Porta

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.
Elena Crisà, Daniela Cilloni, Marta Riva, Enrico Balleari, Daniela Barraco, Matteo Giovanni Della Porta

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VAE-Surv: A novel approach for genetic-based clustering and prognosis prediction in myelodysplastic syndromes.
Cesare Rollo, Corrado Pancotti, Flavio Sartori, Isabella Caranzano, Saverio D'Amico, Matteo Giovanni Della Porta

Comput Methods Programs Biomed· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes.
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, Natthakan Thongon, Feiyang Ma, Matteo Giovanni Della Porta

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.
Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang, Matteo Giovanni Della Porta

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDS.
Angela Consagra, Luca Lanino, Najla H Al Ali, Luis Aguirre, Zhuoer Xie, Matteo G Della Porta

Hemasphere· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis